Exact Mass: 460.2645
Exact Mass Matches: 460.2645
Found 337 metabolites which its exact mass value is equals to given mass value 460.2645
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Sophoranone
A dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 7 and 4 and prenyl groups at positions 3 and 5 respectively.
4,4-Diapolycopene-4,4-dioate
1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate
1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-(8Z,11Z,14Z-eicosatrienoyl)-glycero-3-phosphate is a glycerophosphate lipid molecule
LysoPA(20:3(5Z,8Z,11Z)/0:0)
LysoPA(20:3(5Z,8Z,11Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:3(5Z,8Z,11Z)/0:0), in particular, consists of one chain of mead acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
LysoPA(20:3(8Z,11Z,14Z)/0:0)
LysoPA(20:3(8Z,11Z,14Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(20:3(8Z,11Z,14Z)/0:0), in particular, consists of one chain of dihomo-gamma-linolenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
Fluocortolone Pivalate
2,3-Dihydro-11,11-bis(3-methyl-2-butenyl)-5,6-dihydroxy-2,2,3,8-tetramethylanthra[2,3-b]furan-4(11H)-one
Rudbeckiolide
Sanggenofuran A
Munchiwarin
Sophoradin
(2S)-3,4-dihydro-7-hydroxy-2,2-dimethyl-8,8-bis(3-methylbut-2-enyl)-[2,6-bi-2H-1-benzopyran]-4(3H)-one|tokinochromane B
{(Z)-3-(chloromethylene)-2,3-dihydrobenzo[b]oxepin-7-yl}methyl palmitate
6-[1-hydroxy-3-(4-hydroxyphenyl)allylidene]-2,2,4-tris(3-methylbut-2-enyl)cyclohex-4-ene-1,3-dione|munchiwarin
1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-[4-hydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]prop-2-en-1-one
(2S)-2-[3,4-dihydro-2,2-dimethyl-8-(3-methylbut-2-enyl)-2H-1-benzopyran-6-yl]-2,3,9,10-tetrahydro-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one|tokinochromane A
12-amino-9-sec-butyl-6-(1-hydroxy-1-methyl-propyl)-15-methoxy-4,7,10-triaza-bicyclo[12.3.1]octadeca-1(18),2,14,16-tetraene-5,8,11-trione|Zizyphine E|Zizyphine-E
Ser Ile Asn Lys
Ser Gln Val Lys
Ala Asp Lys Lys
Ala Lys Asp Lys
Ala Lys Lys Asp
Cys Ile Ile Ile
Cys Ile Ile Leu
Cys Ile Leu Ile
Cys Ile Leu Leu
Cys Leu Ile Ile
Cys Leu Ile Leu
Cys Leu Leu Ile
Cys Leu Leu Leu
Asp Ala Lys Lys
Asp Lys Ala Lys
Asp Lys Lys Ala
Glu Gly Lys Lys
Glu Lys Gly Lys
Glu Lys Lys Gly
Phe Pro Val Val
Phe Val Pro Val
Phe Val Val Pro
Gly Glu Lys Lys
Gly Lys Glu Lys
Gly Lys Lys Glu
Ile Cys Ile Ile
Ile Cys Ile Leu
Ile Cys Leu Ile
Ile Cys Leu Leu
Ile Ile Cys Ile
Ile Ile Cys Leu
Ile Ile Ile Cys
Ile Ile Leu Cys
Ile Lys Asn Ser
Ile Lys Ser Asn
Ile Leu Cys Ile
Ile Leu Cys Leu
Ile Leu Ile Cys
Ile Leu Leu Cys
Ile Met Val Val
Ile Asn Lys Ser
Ile Asn Ser Lys
Ile Ser Lys Asn
Ile Ser Asn Lys
Ile Val Met Val
Ile Val Val Met
Lys Ala Asp Lys
Lys Ala Lys Asp
Lys Asp Ala Lys
Lys Asp Lys Ala
Lys Glu Gly Lys
Lys Glu Lys Gly
Lys Gly Glu Lys
Lys Gly Lys Glu
Lys Ile Asn Ser
Lys Ile Ser Asn
Lys Lys Ala Asp
Lys Lys Asp Ala
Lys Lys Glu Gly
Lys Lys Gly Glu
Lys Leu Asn Ser
Lys Leu Ser Asn
Lys Asn Ile Ser
Lys Asn Leu Ser
Lys Asn Ser Ile
Lys Asn Ser Leu
Lys Asn Thr Val
Lys Asn Val Thr
Lys Gln Ser Val
Lys Gln Val Ser
Lys Ser Ile Asn
Lys Ser Leu Asn
Lys Ser Asn Ile
Lys Ser Asn Leu
Lys Ser Gln Val
Lys Ser Val Gln
Lys Thr Asn Val
Lys Thr Val Asn
Lys Val Asn Thr
Lys Val Gln Ser
Lys Val Ser Gln
Lys Val Thr Asn
Leu Cys Ile Ile
Leu Cys Ile Leu
Leu Cys Leu Ile
Leu Cys Leu Leu
Leu Ile Cys Ile
Leu Ile Cys Leu
Leu Ile Ile Cys
Leu Ile Leu Cys
Leu Lys Asn Ser
Leu Lys Ser Asn
Leu Leu Cys Ile
Leu Leu Cys Leu
Leu Leu Ile Cys
Leu Leu Leu Cys
Leu Met Val Val
Leu Asn Lys Ser
Leu Asn Ser Lys
Leu Ser Lys Asn
Leu Ser Asn Lys
Leu Val Met Val
Leu Val Val Met
Met Ile Val Val
Met Leu Val Val
Met Val Ile Val
Met Val Leu Val
Met Val Val Ile
Met Val Val Leu
Asn Ile Lys Ser
Asn Ile Ser Lys
Asn Lys Ile Ser
Asn Lys Leu Ser
Asn Lys Ser Ile
Asn Lys Ser Leu
Asn Lys Thr Val
Asn Lys Val Thr
Asn Leu Lys Ser
Asn Leu Ser Lys
Asn Ser Ile Lys
Asn Ser Lys Ile
Asn Ser Lys Leu
Asn Ser Leu Lys
Asn Thr Lys Val
Asn Thr Val Lys
Asn Val Lys Thr
Asn Val Thr Lys
Pro Phe Val Val
Pro Val Phe Val
Pro Val Val Phe
Gln Lys Ser Val
Gln Lys Val Ser
Gln Ser Lys Val
Gln Ser Val Lys
Gln Val Lys Ser
Gln Val Ser Lys
Ser Ile Lys Asn
Ser Lys Ile Asn
Ser Lys Leu Asn
Ser Lys Asn Ile
Ser Lys Asn Leu
Ser Lys Gln Val
Ser Lys Val Gln
Ser Leu Lys Asn
Ser Leu Asn Lys
Ser Asn Ile Lys
Ser Asn Lys Ile
Ser Asn Lys Leu
Ser Asn Leu Lys
Ser Gln Lys Val
Ser Val Lys Gln
Ser Val Gln Lys
Thr Lys Asn Val
Thr Lys Val Asn
Thr Asn Lys Val
Thr Asn Val Lys
Thr Val Lys Asn
Thr Val Asn Lys
Val Phe Pro Val
Val Phe Val Pro
Val Ile Met Val
Val Ile Val Met
Val Lys Asn Thr
Val Lys Gln Ser
Val Lys Ser Gln
Val Lys Thr Asn
Val Leu Met Val
Val Leu Val Met
Val Met Ile Val
Val Met Leu Val
Val Met Val Ile
Val Met Val Leu
Val Asn Lys Thr
Val Asn Thr Lys
Val Pro Phe Val
Val Pro Val Phe
Val Gln Lys Ser
Val Gln Ser Lys
Val Ser Lys Gln
Val Ser Gln Lys
Val Thr Lys Asn
Val Thr Asn Lys
Val Val Phe Pro
Val Val Ile Met
Val Val Leu Met
Val Val Met Ile
Val Val Met Leu
Val Val Pro Phe
Entereg
C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist D005765 - Gastrointestinal Agents Alvimopan dihydrate (ADL 8-2698 dihydrate) is a potent, selective, orally active and reversible μ-opioid receptor antagonist, with an IC50 of 1.7 nM. Alvimopan dihydrate has selectivity for μ-opioid receptor (Ki=0.47 nM) over κ- and δ-opioid receptors (Kis=100, 12 nM, respectively). Alvimopan dihydrate can be used for the research of postoperative ileus[1][2][3].
Acetylphenylalanyl-prolyl-boroarginine
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
Fluocortolone Pivalate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D000893 - Anti-Inflammatory Agents
1-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methyl]-N-[2-(dipropylamino)ethyl]-4-piperidinecarboxamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
(6S,7R,8aR)-N-[6-(dimethylamino)hexyl]-6-[3-(2-hydroxyethoxy)phenyl]-1,4-dioxo-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-7-carboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-(propan-2-ylamino)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
(2-hydroxy-3-phosphonooxypropyl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[(4E,8E,12E)-2-acetamido-3-hydroxypentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate
(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedioic acid
4,4-diapolycopenedioic acid
An apo carotenoid triterpenoid that is 4,4-diapolycopene in which two of the terminal methyl groups have been oxidised to carboxy groups.